Sonnemann et al. reported that the MDM2 inhibitor Nutlin-3 selectively upregulated P53 gene and protein expression in wild-type P53 Ewing sarcoma cells, leading to significant apoptosis induction. Here, TP53 is linked to Ewing sarcoma.